Osteosarcoma & Ewin's Sarcoma

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 34

OSTEOSARCOMA

EWING’S TUMOR

PRESENTER: ABDUL MUSHIB IBRAHIM

COORDINATOR: DR MAREKO
Osteosarcoma
• DEFINITION:
- is a malignant tumor of the bone.
-there are 2 types:
a)Primary Osteosarcoma
b)Secondary Osteosarcoma

CAUSE: Unknown.
a) Primary Osteosarcoma
• Arises in absence of underling bone disease or
predisposing factors.
• Most common in 2nd decade of life.
• Usually situated in central metaphyseal region
of long Tubular bones.
* Proximal Humerus
* Distal Femur
* Proximal Tibia
Osteosarcoma of Humerus
Osteosarcoma of Humerus
Osteosarcoma of Humerus
Osteosarcoma of Femur
Osteosarcoma of Femur
b) Secondary Osteosarcoma
• Occurs as a background of some predisposing
factor.
• Occurs in other locations (e.g Jaws).
• Usually occurs later in Life.
PREDISPOSING FACTORS
Pagets Disease (common)
Irradiation (Uncommon)
Fibrous Dysplasia (rare)
Diaphyseal Aclasis (Very rare)
PATHOLOGY
• Tumor arises in the metaphseal region of the
bone Extends in all directions.
 Eventually eroding cortex, invading soft
tissues. (Producing obvious extraosseous
mass).
 Codman’s Triangle: When penetrating the
cortex, tumor lifts the periosteum. Angle betn
outer surface of cortex & elevated periosteum
radiologially.
Codman’s Triangle
PATHOLOGY
• Cut surface Grey-white areas of
hemorrhages & necrosis.
• If untreated fungates to produce an
infected malignant ulcer.
* Sometimes the ulcer overlies a
Pathological fracture.
PATHOLOGY
• MICROSCOPIC FEATURE
Formation of osteoid directly by tumor cells.

• SPREAD
Mainly to the Lungs.
CLINICAL FEATURES
• SYMPTOMS
1.Local Pain-Persistant ache or throb.
2.Swelling of Bone.
3.Pathological Fracture.
4.Infected malignant Fracture.
5.General Malaise, cachexia & Weight loss.
6.Cough & Hemoptysis.
CLINICAL FEATURES
• SIGNS
LOCAL SIGNS…..SWELLING
-Usually in lower end of femur, upper end of
tibia & upper end of humerus.
-Colour: affected skin may be reddened.
-Tenderness: Slightly
-Temp: Usually Raised
-Shape: Asymmetrical.
-Surface: Usually smooth but Infected M U
-Composition: Firm & Not Bony Hard
DIAGNOSTIC INVESTIGATIONS
• 1-Radiology
• 2-Histology
DIAGNOSTIC INVESTIGATIONS
1-Radiology
a) Ostcolytic Lesions in bone with ill defined edges.
b)Extension into soft tissues. Neoplastic bone tends
to be deposited as irregular spicules radiating
away from the shaft to give a “sunray”
appearance.
c) Codman’s Triangle.
d)Pathological Fracture.
e) Secondaries to Lung.
DIAGNOSTIC INVESTIGATIONS
2-Histology
a)To confirm the diagnosis.
b)Obtained by: Needle Biopsy or Open Biopsy
TRETMENT OPTIONS
• OPERATIVE
a) Amputation
b)Wide Local resection with replacement of defect
by prosthesis or allograft.
• ADJUVANT CHEMOTHERAPY
Give Postop to control & prevent development of
metastasis.
• TREATMENT OF PULMONARY 2°
a) Solitary: Lobectomy
b)Multiple: Chemo.
PROGNOSIS
• Prognosis is separated into 3 groups.
A.STAGE I
• Is rare.
• Includes perosteal region
• Prognosis > 90% with wide resection.
PROGNOSIS
B.STAGE II
• Depends on site of tumor.
• Size of tumor.
• Degree of necrosis from Chemo.
• Distant Metastatsis to lungs. (Length of time &
Number of Nodules spread over a time span).
• 2-year survival after the metastases-50%, 5-
year-40% and 10 year -20% (2 yrs no spread + <
2 nodules)
PROGNOSIS
C. STAGE III
• Metastasis to lungs
• Depends on removing primary & lung
nodules.
• survival prognosis is about 30%
ANY POINTS FOR DISCUSSION?????????????
EWING’S SARCOMA
DEFINITION
• Is a malignant round cell tumor.
• Initially starts in the bones & may also include
the soft tissues.
• Extraosseous Ewing's sarcoma.
• Exact cell of origin for Ewing's sarcoma. (Oc).

CAUSE: UNKNOWN
• RISK FACTORS: Unknown
• GENETIC FACTORS: Unknown
• PREVENTION: Unknown

• male/female ratio of 1:6


• Peak Age: 10-20 yrs
• affects the long bones, such as:
• Pelvic Bone
• Ribs
• Clavicle
• Femur
• Humerus
• Tibia
SYMPTOMS
• Pain
• Swelling
• tumor may be present for many months
before it becomes large enough to cause pain
and swelling.
• bone weakened by disease may break after a
minor injury.
DIAGNOSING
• Hx
• Imaging: X-ray, CT, MRI, Bone Scan.
• X-Ray will show “ONION SKIN” type periosteal
reaction
• BIOPSY
• Chromosomes #11 and #22 are affected.
X-ray
TREATMENT
• NON OPERATIVE
Chemotherapy: vincristine , dactinomycin,
cyclophosphamide and doxorubicin
• OPERATIVE
Surgery
• RADIATION Therapy
PROGNOSIS
• Five-year survival for localized disease is 70%
to 80% when treated with chemotherapy.
• Long term survival for metastatic disease can
be less than 10%
Any Points For DISCUSSION

THANK YOU FOR YOUR TIME

You might also like